Phase 2 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a mucosal tumour (a tumour on the moist lining of a body cavity) that can be seen on a physical exam or imaging scan.
- People whose cancer has not spread to distant parts of the body.
- People who are already planned to receive a combination immunotherapy treatment (such as ipilimumab and nivolumab, or nivolumab and relatlimab).
- People who are reasonably well and able to carry out some daily activities (confirm with trial site regarding the specific activity level required).
- People aged 18 years or older.
- People of childbearing potential, and their male partners, who agree to use effective contraception throughout the trial and for a set period afterward — acceptable methods include hormonal contraception, an intrauterine device (IUD), surgical sterilisation, vasectomy, or condoms with spermicide; complete abstinence during the trial period is also accepted.
- Men enrolled in the trial who agree to use effective contraception before, during, and for 6 months after completing radiation therapy.
- People who have had or currently have another type of cancer, where that cancer or its treatment is not expected to interfere with safely receiving the treatments in this study.
- People who are able to understand the trial and are willing to sign a written consent form.
- For the sinonasal melanoma group (Arm 1): People who have been confirmed by biopsy or cell testing to have melanoma in the nasal cavity and/or sinuses, who have been assessed by a head and neck surgeon regarding whether surgery is possible, and who are able to have a baseline MRI scan of the skull base (unless there is a medical or financial reason they cannot).
- For the anorectal melanoma group (Arm 2): People who have been confirmed by biopsy or cell testing to have melanoma in the anorectal canal, who have been assessed by a surgical team regarding surgical options, and who are able to have a baseline rectal MRI scan (unless there is a medical or financial reason they cannot).
Who may not be able to join:
- People who have previously had radiation therapy to the area of the body that would be treated in this trial (the nose/sinus area for Arm 1, or the anorectal area for Arm 2).
- People whose cancer has already spread (metastatic disease).
- People who are currently pregnant.
- People under 18 years of age.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Devarati Mitra, MD, M.D. Anderson Cancer Center
Phone: (713) 563-1339
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of Pathologic Response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.